Table 3.

Transplant type/clinicohistologic diagnosis and results of adherence assays

Adherence assayAll patients, first biopsy only; n = 47,
clinicohistologic diagnosis3-150
Allogeneic transplant patients, all biopsies; n = 40,
clinicohistologic diagnosis3-151
Non-GVHD,
autologous
GVHDNon-GVHD,
allogeneic
GVHDNon-GVHD
15 23-152 24 23-152 
− 20 33-153 11 
Adherence assayAll patients, first biopsy only; n = 47,
clinicohistologic diagnosis3-150
Allogeneic transplant patients, all biopsies; n = 40,
clinicohistologic diagnosis3-151
Non-GVHD,
autologous
GVHDNon-GVHD,
allogeneic
GVHDNon-GVHD
15 23-152 24 23-152 
− 20 33-153 11 
F3-150

P < .000001, two-tailed (by χ2 test) for all patients, first biopsy only.

F3-151

P = .00001, two-tailed (by Fisher exact test) for allogeneic transplant patients, all biopsies.

F3-152

On rebiopsy, both patients met clinicohistologic criteria for acute cutaneous GVHD.

F3-153

These 3 patients were receiving steroids for therapy of GVHD at time of biopsy (second biopsy), and all had subsequent clinical resolution of skin GVHD.

or Create an Account

Close Modal
Close Modal